军事知识服务平台
四川大学华西医院慢性病共病全程管理服务模式探索
Exploration on a whole-process management service mode for multiple chronic conditions in West China Hospital of Sichuan University
摘要 慢性病共病管理是我国公共卫生领域的重要议题。传统诊疗模式难以满足共病患者复杂的健康需求,亟需探索多学科服务新模式。2025年10月,四川大学华西医院在原有慢性病全程管理的基础上,探索了慢性病共病全程管理服务模式:通过设立全程与共病管理中心,配备专病管理师、专病数据库管理师和专病推广师,聚焦共病全程主动健康干预,以全人照护、全程衔接、主动服务和协同赋能为原则,从建机构、建机制、建模式和建体系4个维度系统推进共病管理。医院基于该模式,针对门诊、手术和体检3类临床场景,开展了常见慢性病共病门诊管理、围手术期共病管理和异常指标主动干预的全链条服务。截至2026年2月,共病门诊累计接诊210人次,涉及2个及以上专科用药患者的药物重整率为100%;随访平台完成智能随访70余万次,随访患者满意度97.88%。该实践初步实现了共病患者"一次挂号、多科协同"的一站式服务,可为我国公立医院推进慢性病共病综合防治,实现医疗服务模式转型提供参考。
Abstract:
The whole-process management for multiple chronic conditions had become a critical issue in the field of public health in China. Traditional diagnostic and treatment mode struggled to meet the complex health needs of patients with comorbidities. It was necessary to explore the new multidisciplinary care mode. In October 2025, West China Hospital of Sichuan University, building on its existing comprehensive management of chronic diseases, explored a whole-process management service mode for multiple chronic conditions. This mode established a whole-process comorbidity management centers staffed with specialized disease managers, specialized disease database administrators, and specialized disease outreach specialists. It focused on proactive health interventions throughout the entire course of comorbidity management, guided by the principles of holistic care, seamless coordination, proactive service, and collaborative empowerment. It systematically advanced comorbidity management across four dimensions: establishing institutions, mechanisms, models, and systems. Based on this mode, the hospital had implemented the end-to-end services for three types of clinical scenarios (outpatient care, surgery and health checkups), including comorbidity outpatient management, perioperative comorbidity management, and proactive intervention for abnormal test results. As of February 2026, the comorbidity outpatient department had treated 210 patients, with a 100% rate for medication reconciliation involving two or more sepcialties; the follow-up platform had completed more than 700 thousand follow-ups, with a patient satisfaction rate of 97.88%. This practice had provided a one-stop service for patients with comorbidities, featuring " a single registration for multidisciplinary collaboration", which could serve as a reference for China′s public hospitals in advancing the comprehensive prevention and treatment of chronic comorbidities and transforming their healthcare service modes.